Arcturus Therapeutics (ARCT) PT Raised to $44 at Baird
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Price: $14.85 +6.22%
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Baird analyst Madhu Kumar raised the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $44.00 (from $26.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
- Adani Ports & Special Economic Zone (ADSEZ:IN) PT Raised to INR2,100 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
